Georgia Hatzivassiliou

mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells.

Anneleen Daemen, Min Gao, Marie Evangelista, 2016, Cancer cell.

Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis

Chi Li, Junying Yuan, Craig B. Thompson, 2003, The Journal of cell biology.

ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors

Wei Zhou, William F. Forrest, Sherry Heldens, 2012, Molecular Cancer Therapeutics.

ATP-Citrate Lyase Links Cellular Metabolism to Histone Acetylation

Justin R. Cross, Craig B. Thompson, K. Wellen, 2009, Science.

Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers

Ariana Peck, Shiuh-Ming Luoh, Steve Price, 2013, Nature.

Live-Cell Microscopy Reveals Small Molecule Inhibitor Effects on MAPK Pathway Dynamics

G. Hatzivassiliou, Kyung Song, Daniel J. Anderson, 2011, PloS one.

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Anneleen Daemen, Deepak Sampath, Gerard Manning, 2015, Proceedings of the National Academy of Sciences.

Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors.

Tyler Risom, Zhaoyang Wen, Ignacio Aliagas, 2011, ACS medicinal chemistry letters.

ATP citrate lyase inhibition can suppress tumor cell growth.

Daniel E Bauer, Dashyant Dhanak, D. Tuveson, 2005, Cancer cell.